COL1A2, a key gene associated with NAFLD progression, is predominantly expressed and upregulated in fibroblasts linked to HCC and is significantly correlated with the epithelial–mesenchymal transition (EMT) and angiogenesis in various cancers [131]. The gene discussed is COL1A2; the disease is metabolic dysfunction-associated steatotic liver disease.